Renaissance Technologies Portfolio holdings
Renaissance Technologies is a hedge fund firm that trades with computer models built on mathematics and statistics. It began in 1978 as Monemetrics, founded by Jim Simons, a mathematician and former Cold War codebreaker, and took its current name in 1982. The firm launched its Medallion Fund in 1988 and staffs its research with mathematicians, statisticians, physicists, astronomers and computer scientists. Medallion trades over short time spans across many asset types, and it has been closed to outside investors since 1993, open only to current and past employees and their families.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Healthcare | 16.97% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$178B
| $1.52B | 2.19% |
18,741,976
-2,862,600
| -13% | -$234M |
2013 Q2
40 quarters
|
|
|
2
Meta Platforms (Facebook)
META
$1.56T
| $1.3B | 1.87% |
4,532,030
+2,623,447
| +137% | +$647M |
2021 Q3
7 quarters
|
|
|
3
Apple
AAPL
$4.98T
| $955M | 1.38% |
4,921,796
+4,912,234
| +51,372% | +$856M |
2020 Q3
11 quarters
|
|
|
4
NVIDIA
NVDA
$4.51T
| $785M | 1.13% |
18,559,040
+18,527,120
| +58,042% | +$615M |
2023 Q1
1 quarter
|
|
5
VeriSign
VRSN
$27.7B
| $691M | 1% |
3,056,590
-126,500
| -4% | -$27.9M |
2013 Q2
40 quarters
|
|
6
Airbnb
ABNB
$112B
| $679M | 0.98% |
5,294,527
-760,029
| -13% | -$88.9M |
2021 Q2
8 quarters
|
|
7
Palantir
PLTR
$386B
| $610M | 0.88% |
39,799,157
-814,600
| -2% | -$9.26M |
2021 Q2
8 quarters
|
|
8
Gilead Sciences
GILD
$207B
| $600M | 0.86% |
7,781,416
-2,802,800
| -26% | -$224M |
2014 Q4
34 quarters
|
|
9
Hershey
HSY
$35.8B
| $573M | 0.83% |
2,295,767
-7,600
| -0.3% | -$1.99M |
2013 Q2
40 quarters
|
|
10
Fortinet
FTNT
$87.3B
| $552M | 0.8% |
7,306,045
+1,075,400
| +17% | +$73.1M |
2015 Q3
31 quarters
|
|
|
11
Tesla
TSLA
$1.42T
| $548M | 0.79% |
2,091,807
-1,933,244
| -48% | -$387M |
2018 Q4
18 quarters
|
|
12
Franco-Nevada
FNV
$49.2B
| $499M | 0.72% |
3,500,703
+27,200
| +0.8% | +$4.08M |
2014 Q1
37 quarters
|
|
13
United Therapeutics
UTHR
$23.9B
| $483M | 0.7% |
2,187,214
-40,200
| -2% | -$8.9M |
2013 Q2
40 quarters
|
|
14
Boeing
BA
$137B
| $467M | 0.67% |
2,209,700
-382,400
| -15% | -$79.4M |
2022 Q4
2 quarters
|
|
15
Uber
UBER
$140B
| $449M | 0.65% |
10,390,900
+5,767,500
| +125% | +$214M |
2021 Q2
8 quarters
|
|
16
Vertex Pharmaceuticals
VRTX
$139B
| $448M | 0.65% |
1,272,161
-125,574
| -9% | -$42.3M |
2017 Q1
25 quarters
|
|
17
CrowdStrike
CRWD
$222B
| $420M | 0.61% |
11,445,316
+283,716
| +3% | +$9.9M |
2020 Q1
13 quarters
|
|
18
Kroger
KR
$40B
| $395M | 0.57% |
8,399,754
-1,629,100
| -16% | -$77.7M |
2019 Q2
16 quarters
|
|
19
Snowflake
SNOW
$97.3B
| $387M | 0.56% |
2,198,699
-223,900
| -9% | -$36.4M |
2022 Q1
5 quarters
|
|
20
Zoom
ZM
$26.2B
| $372M | 0.54% |
5,486,068
-1,087,347
| -17% | -$72.7M |
2020 Q1
13 quarters
|
|
21
Atlassian
TEAM
$38.9B
| $369M | 0.53% |
2,201,223
+468,300
| +27% | +$75M |
2016 Q2
28 quarters
|
|
|
HZNP
22
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $355M | 0.51% |
3,448,749
+80,300
| +2% | +$8.47M |
2017 Q2
24 quarters
|
|
23
Caterpillar
CAT
$256B
| $330M | 0.48% |
1,340,010
-148,790
| -10% | -$33.2M |
2022 Q4
2 quarters
|
|
24
lululemon athletica
LULU
$12.8B
| $329M | 0.47% |
868,800
+103,400
| +14% | +$38.2M |
2023 Q1
1 quarter
|
|
25
Chipotle Mexican Grill
CMG
$43.6B
| $328M | 0.47% |
7,670,000
+7,355,000
| +2,335% | +$291M |
2022 Q2
4 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 596 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 539 new positions and closed 596 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.